COAG
Hemab Therapeutics Holdings, Inc.
39.33
+0.56 (+1.44%)
52w low 23.00
55.42 high
50.4% of range
Financial Analysis
| (USD) | Dec 24 | Dec 25 | Trend |
|---|---|---|---|
| Operating Cash Flow | -45.59M | -61.48M | |
| Depreciation & Amort | 248.00K | 304.00K | |
| Capital Expenditure | -282.00K | -16.00K | |
| Free Cash Flow | -45.87M | -61.49M | |
| Investing Cash Flow | 61.90M | -81.48M | |
| Financing Cash Flow | -100.00K | 156.30M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--